Target Patient Population: Patients with CKD and T2D

Study Overview: To assess the efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin alone in participants with chronic kidney disease and type 2 diabetes

Study Timeline: Anticipated patient participation is 8 Months, 7 visits to the clinic

Number of Patients Currently Active in the Trial: 3

670 Glades Rd. Suite 110 Boca Raton, FL 33431P. (561) 368-0235 | F. (561) 368-0281